Holen Sie sich die Stockscreener-App
24.06
4.11%
0.95
Handel nachbörslich:
24.07
0.01
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$23.11
Offen:
$24.5
24-Stunden-Volumen:
33.04M
Relative Volume:
1.91
Marktkapitalisierung:
$45.97B
Einnahmen:
$15.46B
Nettoeinkommen (Verlust:
$1.03B
KGV:
45.40
EPS:
0.53
Netto-Cashflow:
$1.34B
1W Leistung:
+0.42%
1M Leistung:
+11.96%
6M Leistung:
+1.60%
1J Leistung:
+17.65%
1-Tages-Spanne:
$23.97
$25.17
1-Wochen-Bereich:
$23.00
$25.17
52-Wochen-Spanne:
$17.67
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Vergleichen Sie KVUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
24.06 | 45.97B | 15.46B | 1.03B | 1.34B | 0.53 |
|
PG
Procter Gamble Co
|
158.65 | 375.08B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
62.58 | 160.71B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
90.83 | 77.71B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KMB
Kimberly Clark Corp
|
133.54 | 43.09B | 19.75B | 2.47B | 2.39B | 7.34 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
| 2025-03-24 | Eingeleitet | Evercore ISI | In-line |
| 2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Eingeleitet | Jefferies | Buy |
| 2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Fortgesetzt | Citigroup | Neutral |
| 2024-04-11 | Eingeleitet | Bernstein | Underperform |
| 2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
| 2024-03-01 | Fortgesetzt | Goldman | Neutral |
| 2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-09-06 | Eingeleitet | Argus | Hold |
| 2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-25 | Eingeleitet | Edward Jones | Buy |
| 2023-06-01 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Eingeleitet | BofA Securities | Buy |
| 2023-05-30 | Eingeleitet | Citigroup | Neutral |
| 2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
| 2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-05-30 | Eingeleitet | Goldman | Neutral |
| 2023-05-30 | Eingeleitet | JP Morgan | Overweight |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Kenvue’s Earnings Call: Mixed Sentiment Amidst Challenges - TipRanks
Alteri Wealth LLC Makes New $293,000 Investment in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Barbie maker Mattel taps Kenvue’s Paul Ruh as CFO By Reuters - Investing.com
Barbie maker Mattel taps Kenvue's Paul Ruh as CFO - StreetInsider
Neutrogena-Maker Kenvue Beats Profit Forecast, Ups Sales Outlook - AOL.com
Kenvue: Q1 Earnings Snapshot - Stamford Advocate
Piper Sandler Adjusts Price Target on Kenvue to $29 From $27, Keeps Overweight Rating - marketscreener.com
Kenvue (NYSE:KVUE) Appoints New CFO as 2025 Sales Increase 1%-3% - Yahoo Finance
Kellanova CFO jumps to J&J spinoff Kenvue - CFO Dive
Kenvue Works on SHB Recovery Plan While Other Categories Show Stability; Tariff Impact Mild - Morningstar
Kenvue expects flat profit as $150 million tariff hit looms - MSN
Kenvue rises after quarterly results beat - TradingView
Kenvue Reports Upbeat Q1 Earnings, Revises Outlook: But Retail’s Unmoved - MSN
Earnings call transcript: Kenvue’s Q1 2025 results exceed expectations, stock surges - Investing.com
Compared to Estimates, Kenvue (KVUE) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Kenvue Boosts 2025 Sales Growth View - WSJ
Kenvue Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:KVUE) - Seeking Alpha
Kenvue Q1 2025 slides: Organic sales decline amid strategic investments, outlook maintained By Investing.com - Investing.com Australia
Tylenol-Maker Kenvue Keeps Growth Outlook, Lowers Margin Target - Bloomberg.com
Kenvue stock climbs as second quarter comes in ahead of forecasts - Proactive Investors
Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Net Sales Outlook - Investopedia
Kenvue Announces Chief Financial Officer Transition, Effective May 12, 2025 - marketscreener.com
Kenvue first-quarter results beat estimates helped by strong demand for self care products - marketscreener.com
Kenvue (KVUE) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Warner Bros, Arm and Peloton fall premarket; Tapestry, Kenvue rise By Investing.com - Investing.com Australia
Warner Bros, Arm and Peloton fall premarket; Tapestry, Kenvue rise - Investing.com
U.S. STOCKS ON THE MOVE-Intel, Occidental Petroleum, Kenvue - TradingView
Kenvue Appoints Amit Banati as New CFO - TipRanks
Kenvue’s Q2 earnings, revenue beat expectations By Investing.com - Investing.com Canada
Kenvue first-quarter results beat estimates on strength in self care unit By Reuters - Investing.com
Kenvue first-quarter results beat estimates on strength in self care unit - marketscreener.com
Kenvue Appoints New Chief Financial Officer - Beauty Packaging
Kenvue names Amit Banati as new CFO from May 12 - Investing.com
Kenvue Expects Flat Profit as $150 Million Tariff Hit Looms - U.S. News & World Report
Kenvue names Amit Banati as new CFO from May 12 By Investing.com - Investing.com Australia
Kenvue Inc. Q1 Profit Increases, Beats Estimates - Nasdaq
Kenvue Reports First Quarter 2025 Results - Business Wire
Kenvue Announces Chief Financial Officer Transition - Business Wire
Investors Fight J&J, Kenvue IPO Fraud Suit Dismissal - USA Herald
Alyeska Investment Group L.P. Grows Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Marshall Wace LLP Sells 1,628,800 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Ancora Advisors LLC Raises Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Investors Fight J&J, Kenvue Bid To Nix IPO Fraud Suit - Law360
Comerica Bank Has $14.07 Million Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue (KVUE) Prepares for Q1 Earnings with Anticipated Decline - GuruFocus
Gordon Haskett says California Tylenol case dismissal ‘significant’ Kenvue win - Yahoo Finance
Tylenol maker Kenvue integrates sustainability into product design process - Trellis Group
Kenvue (NYSE:KVUE) Reaches New 12-Month HighTime to Buy? - MarketBeat
KENVUE Earnings Preview: Recent $KVUE Insider Trading, Hedge Fund Activity, and More - Nasdaq
Kenvue Earnings Preview: What to Expect - MSN
Kenvue (KVUE) Achieves Legal Victory in California Tylenol Lawsu - GuruFocus
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):